Robin heads the Centre for Psychedelic Research at Imperial College London, the first of its kind, supported by about £3m in philanthropic donations. The Psychedelic Research Group at Imperial focuses on two main research areas: the action of psychedelic drugs in the brain, and their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression. For 15 years, his research has focused on how drugs such as LSD, psilocybin, DMT and MDMA work in the brain, and how they may be useful in treating disorders such as depression.
